Novartis disputes U.S. senators’ report on Cohen contract


ZURICH (Reuters) – Novartis (NOVN.S) on Friday disputed a report from Democratic U.S. senators that concluded the Swiss drugmaker misled the public about its $1.2 million contract with a former attorney for President Donald Trump.

FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

“We disagree with the report’s conclusion that we issued a misleading public statement regarding the extent of our engagement with (Michael) Cohen,” Novartis said of the report…



Read More Here

Be the first to comment on "Novartis disputes U.S. senators’ report on Cohen contract"

Leave a comment

Your email address will not be published.


*